Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.51 USD | +0.45% | -5.65% | +72.80% |
May. 07 | Citigroup Starts Summit Therapeutics With Buy Rating, $7 Price Target | MT |
May. 01 | Transcript : Summit Therapeutics Inc., Q1 2024 Earnings Call, May 01, 2024 |
Official Publications
No official publication found
- Stock Market
- Equities
- SMMT Stock
- News Summit Therapeutics Inc.
- Official Publications